ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO762

Infections of Tunneled and Non-Tunneled Central Venous Catheters Associated with the Use of 10% Povidone-Iodine versus 2% Chlorhexidine in Chronic Hemodialysis

Session Information

Category: Dialysis

  • 603 Hemodialysis: Vascular Access

Authors

  • Arvizu-Hernandez, Mauricio, National Medical Science and Nutrition Institute Salvador Zubiran, México city, México city, Mexico
  • Vega, Olynka, National Institute of Medical Sciences, Mexico, Distrito Federal, Mexico
  • Correa-Rotter, Ricardo, National Medical Science and Nutrition Institute Salvador Zubiran, México city, México city, Mexico
Background

Vascular access (VA) infections are a problem in patients on hemodialysis (HD), representing the second cause of morbidity and mortality. The ideal VA is the arterio-venous fistula, in our environment a high number of patients start and stay for a longer than desired on catheters. The use of 2% chlorhexidine solution (2% CHX) for the management of exit site of VA on HD can impact positively the number of catheter infections.

Methods

Retrospective cohort study performed in our Institute HD unit, where 10% povidone-iodine solution (PI) was previously used and since March/2015, was substituted by 2% CHX. We assessed the rate of VA (cathether related) infections from Sep/13 to Aug/16 (Sept/13-Feb/2015 PI and Mar/15-Aug/16 use of 2% CHX). Incidence of infections was analyzed on a monthly basis, identifying number and clinical characteristics of the infection. We calculated the rate of infections per 1000 days/cath/patient. The use of PI vs 2% CHX periods were compared.

Results

During the 36 month study period, a total of 33 infections were identified (0,91 infect/month). The highest infection rate was observed during the use of the PI, both in tunneled and non-tunneled catheters. On the basis of cumulative incidence rates, calculating the RR; the use of PI in both types of catheters, as compared to use of 2% CHX, has a RR of 4.0 (tunneled RR=3.6 and non-tunneled RR=7.0).

Conclusion

Our study demonstrated clearly that the use of 2% CHX in patients with temporary cathether vascular accesses on HD, reduces the risk of infection of both the tunneled and non-tunneled catheters.